Accolade Inc.

9.75-0.3600-3.56%Vol 1.25M1Y Perf -
Oct 4th, 2023 16:00 DELAYED
BID9.10 ASK9.82
Open10.12 Previous Close10.11
Pre-Market- After-Market9.77
 - -  0.02 0.21%
Target Price
13.63 
Analyst Rating
Moderate Buy 1.57
Potential %
39.79 
Finscreener Ranking
★★★     49.76
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     49.90
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★+     40.97
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
28.70 
Earnings Rating
Market Cap717.93M 
Earnings Date
4th Oct 2023
Alpha-0.02 Standard Deviation0.21
Beta1.81 

Today's Price Range

9.7310.21

52W Range

6.8317.01

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-
1 Month
-
3 Months
-
6 Months
-
1 Year
-
3 Years
-73.90%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ACCD9.75-0.3600-3.56
AAPL173.661.26000.73
GOOG136.272.97002.23
MSFT318.965.56501.78
XOM111.50-4.3300-3.74
WFC38.970.30000.78
JNJ155.520.18000.12
FB196.640.99000.51
GE108.851.09001.01
JPM143.350.64000.45
Financial StrengthValueIndustryS&P 500US Markets
3.20
3.30
0.38
0.63
-166.10
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
46.90
-112.90
-99.70
-45.50
-30.72
RevenueValueIndustryS&P 500US Markets
266.93M
3.71
22.77
-
Earnings HistoryEstimateReportedSurprise %
Q01 2024-0.64-0.5218.75
Q04 2023-0.43-0.422.33
Q03 2023-0.61-0.568.20
Q02 2023-0.71-0.667.04
Q01 2023-0.95-0.6234.74
Q04 2022-0.45-0.59-31.11
Q03 2022-0.68-0.654.41
Q02 2022-0.53-0.67-26.42
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Oct 2023
Estimated EPS Next Report-0.56
Estimates Count8
EPS Growth Next 5 Years %-
Volume Overview
Volume1.25M
Shares Outstanding73.63K
Shares Float62.22M
Trades Count12.03K
Dollar Volume12.39M
Avg. Volume767.23K
Avg. Weekly Volume526.54K
Avg. Monthly Volume783.31K
Avg. Quarterly Volume991.84K

Accolade Inc. (NASDAQ: ACCD) stock closed at 17.98 per share at the end of the most recent trading day (a -1.86% change compared to the prior day closing price) with a volume of 972.61K shares and market capitalization of 717.93M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 1230 people. Accolade Inc. CEO is Rajeev Singh.

The one-year performance of Accolade Inc. stock is %, while year-to-date (YTD) performance is -43.77%. ACCD stock has a five-year performance of %. Its 52-week range is between 6.83 and 17.005, which gives ACCD stock a 52-week price range ratio of 28.70%

Accolade Inc. currently has a PE ratio of -1.30, a price-to-book (PB) ratio of 1.06, a price-to-sale (PS) ratio of 2.09, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -39.92%, a ROC of -43.33% and a ROE of -71.05%. The company’s profit margin is -30.72%, its EBITDA margin is -99.70%, and its revenue ttm is $266.93 Million , which makes it $3.71 revenue per share.

Of the last four earnings reports from Accolade Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.56 for the next earnings report. Accolade Inc.’s next earnings report date is 04th Oct 2023.

The consensus rating of Wall Street analysts for Accolade Inc. is Moderate Buy (1.57), with a target price of $13.63, which is +39.79% compared to the current price. The earnings rating for Accolade Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Accolade Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Accolade Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.18, ATR14 : 1.29, CCI20 : 158.09, Chaikin Money Flow : 0.02, MACD : 0.00, Money Flow Index : 63.98, ROC : 39.16, RSI : 0.00, STOCH (14,3) : 86.83, STOCH RSI : 0.00, UO : 62.70, Williams %R : -13.17), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Accolade Inc. in the last 12-months were: Barnes Stephen (Option Excercise at a value of $0), Barnes Stephen (Sold 6 824 shares of value $84 909 ), Barnes Stephen H. (Sold 2 576 shares of value $35 575 ), Brodsky Jeffrey (Option Excercise at a value of $0), Cavanaugh Robert (Option Excercise at a value of $0), Cavanaugh Robert (Sold 7 350 shares of value $91 111 ), Cavanaugh Robert N (Sold 2 511 shares of value $34 677 ), Colin McHugh (Sold 0 shares of value $0 ), Colin McHugh (Sold 728 shares of value $10 161 ), Eskew Richard (Sold 489 shares of value $7 024 ), Hilton Michael (Option Excercise at a value of $0), Hilton Michael (Sold 3 326 shares of value $37 419 ), Jeffrey S. Brodsky (Option Excercise at a value of $0), McHugh Colin (Sold 370 shares of value $5 315 ), Michael W. Hilton (Option Excercise at a value of $0), Michael W. Hilton (Sold 890 shares of value $8 949 ), Nabel Elizabeth (Sold 0 shares of value $0 ), Peter S. Klein (Option Excercise at a value of $0), Rajeev Singh (Option Excercise at a value of $0), Rajeev Singh (Sold 1 171 shares of value $12 216 ), Richard Eskew (Option Excercise at a value of $5 065), Richard Eskew (Sold 4 102 shares of value $51 096 ), Robert Cavanaugh (Option Excercise at a value of $0), Robert Cavanaugh (Sold 814 shares of value $8 628 ), Singh Rajeev (Option Excercise at a value of $1 829 096), Singh Rajeev (Sold 18 039 shares of value $227 458 ), Stephen Barnes (Option Excercise at a value of $0), Stephen Barnes (Sold 631 shares of value $6 699 ), Thomas J. Neff (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
9 (64.29 %)
10 (62.50 %)
10 (62.50 %)
Moderate Buy
2 (14.29 %)
2 (12.50 %)
2 (12.50 %)
Hold
3 (21.43 %)
4 (25.00 %)
4 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.57
Moderate Buy
1.63
Moderate Buy
1.63

Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. it generates revenue through providing personalized health guidance solutions to members.

CEO: Rajeev Singh

Telephone: +1 206 926-8100

Address: 1201 Third Avenue, Seattle 98101, WA, US

Number of employees: 1 230

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

59%41%

Bearish Bullish

60%40%

 

TipRanks News for ACCD


News

Stocktwits